OncoBEAM™ RAS CRC Kit offers the following advantages:

  • High Concordance with Tissue
    OncoBEAM™ RAS CRC Kit demonstrated an overall percent agreement of 93.3 % with tissue
  • Safety and Convenience
    Minimally invasive, few risks
  • Accurate Information
    Blood sample evaluation represents current mutational status of patient’s disease; Information of tumor dynamics in real time
  • No Selection Bias
    Evaluate primary tumor and metastases with one sample
  • Ability to Monitor
    Allows multiple measurements to assess drug response and resistance
  • Time Sensitive
    Rapid turnaround time from biopsy to result
Add Enquiry
I agree that Sysmex will store and process the above information in order to evaluate my request and reply as set out in the Privacy Policy.*